Latest SECTOR GAMMA AS Stock Portfolio
SECTOR GAMMA AS Performance:
2024 Q3: 5.97%YTD: 1.58%2023: -2%
Performance for 2024 Q3 is 5.97%, and YTD is 1.58%, and 2023 is -2%.
About SECTOR GAMMA AS and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, SECTOR GAMMA AS reported an equity portfolio of $329.6 Millions as of 30 Sep, 2024.
The top stock holdings of SECTOR GAMMA AS are BMY, MDT, GILD. The fund has invested 9.4% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 9.2% of portfolio in MEDTRONIC PLC.
The fund managers got completely rid off ABBOTT LABS (ABT), ALNYLAM PHARMACEUTICALS INC (ALNY) and VIATRIS INC (VTRS) stocks. They significantly reduced their stock positions in TENET HEALTHCARE CORP (THC), UNIVERSAL HLTH SVCS INC (UHS) and ALKERMES PLC (ALKS). SECTOR GAMMA AS opened new stock positions in BECTON DICKINSON & CO (BDX), BIONTECH SE and HUMANA INC (HUM). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN), QIAGEN NV and CENTENE CORP DEL (CNC).
The top stock holdings of SECTOR GAMMA AS are BMY, MDT, GILD. The fund has invested 9.4% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 9.2% of portfolio in MEDTRONIC PLC.
The fund managers got completely rid off ABBOTT LABS (ABT), ALNYLAM PHARMACEUTICALS INC (ALNY) and VIATRIS INC (VTRS) stocks. They significantly reduced their stock positions in TENET HEALTHCARE CORP (THC), UNIVERSAL HLTH SVCS INC (UHS) and ALKERMES PLC (ALKS). SECTOR GAMMA AS opened new stock positions in BECTON DICKINSON & CO (BDX), BIONTECH SE and HUMANA INC (HUM). The fund showed a lot of confidence in some stocks as they added substantially to BIOMARIN PHARMACEUTICAL INC (BMRN), QIAGEN NV and CENTENE CORP DEL (CNC).
SECTOR GAMMA AS Annual Return Estimates Vs S&P 500
Our best estimate is that SECTOR GAMMA AS made a return of 5.97% in the last quarter. In trailing 12 months, it's portfolio return was 6.7%.
New Buys
| Ticker | $ Bought |
|---|---|
| becton dickinson & co | 18,632,200 |
| biontech se | 4,750,800 |
| humana inc | 3,800,880 |
| legend biotech corp | 1,888,870 |
New stocks bought by SECTOR GAMMA AS
Additions
| Ticker | % Inc. |
|---|---|
| biomarin pharmaceutical inc | 200 |
| qiagen nv | 167 |
| centene corp del | 111 |
| edwards lifesciences corp | 53.5 |
| baxter intl inc | 48.08 |
| bruker corp | 37.67 |
| cvs health corp | 37.27 |
| incyte corp | 27.35 |
Additions to existing portfolio by SECTOR GAMMA AS
Reductions
| Ticker | % Reduced |
|---|---|
| tenet healthcare corp | -50.13 |
| universal hlth svcs inc | -49.64 |
| alkermes plc | -48.45 |
| amgen inc | -46.67 |
| agios pharmaceuticals inc | -44.27 |
| gilead sciences inc | -31.18 |
| biogen inc | -20.05 |
| pfizer inc | -8.38 |
SECTOR GAMMA AS reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| viatris inc | -1,096,020 |
| abbott labs | -7,273,700 |
| alnylam pharmaceuticals inc | -3,703,320 |
SECTOR GAMMA AS got rid off the above stocks
Sector Distribution
SECTOR GAMMA AS has about 91.9% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 91.9 |
| Others | 8.1 |
Market Cap. Distribution
SECTOR GAMMA AS has about 81.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 81.4 |
| MID-CAP | 10.4 |
| UNALLOCATED | 8.1 |
Stocks belong to which Index?
About 80.6% of the stocks held by SECTOR GAMMA AS either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| S&P 500 | 77.8 |
| Others | 19.4 |
| RUSSELL 2000 | 2.8 |
SECTOR GAMMA AS Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of SECTOR GAMMA AS
SECTOR GAMMA AS has 29 stocks in it's portfolio. About 62.4% of the portfolio is in top 10 stocks. BMRN proved to be the most loss making stock for the portfolio. BMY was the most profitable stock for SECTOR GAMMA AS last quarter.
Last Reported on: 13 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABT | abbott labs | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGIO | agios pharmaceuticals inc | 0.92 | 67,908 | 3,017,150 | reduced | -44.27 | ||
| ALKS | alkermes plc | 0.85 | 100,000 | 2,799,000 | reduced | -48.45 | ||
| ALNY | alnylam pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AMGN | amgen inc | 1.56 | 16,000 | 5,155,360 | reduced | -46.67 | ||
| BAX | baxter intl inc | 4.43 | 385,000 | 14,618,400 | added | 48.08 | ||
| BDX | becton dickinson & co | 5.65 | 77,280 | 18,632,200 | new | |||
| BIIB | biogen inc | 2.07 | 35,166 | 6,816,580 | reduced | -20.05 | ||
| BIO | bio rad labs inc | 1.71 | 16,829 | 5,630,650 | unchanged | 0.00 | ||
| BMRN | biomarin pharmaceutical inc | 4.06 | 190,348 | 13,379,600 | added | 200 | ||
| BMY | bristol-myers squibb co | 9.45 | 602,000 | 31,147,500 | added | 12.52 | ||
| BRKR | bruker corp | 3.33 | 158,970 | 10,978,500 | added | 37.67 | ||
| CAH | cardinal health inc | 3.93 | 117,098 | 12,941,700 | added | 9.34 | ||
| CNC | centene corp del | 2.17 | 95,000 | 7,151,600 | added | 111 | ||
| CVS | cvs health corp | 5.76 | 302,000 | 18,989,800 | added | 37.27 | ||
| ELV | elevance health inc | 4.15 | 26,279 | 13,665,100 | added | 8.24 | ||
| EW | edwards lifesciences corp | 2.12 | 106,153 | 7,005,040 | added | 53.5 | ||
| GILD | gilead sciences inc | 7.36 | 289,163 | 24,243,400 | reduced | -31.18 | ||
| HUM | humana inc | 1.15 | 12,000 | 3,800,880 | new | |||
| INCY | incyte corp | 5.19 | 259,000 | 17,119,900 | added | 27.35 | ||